MENU
+Compare
MRK
Stock ticker: NYSE
AS OF
Mar 28 closing price
Price
$89.23
Change
+$1.63 (+1.86%)
Capitalization
331.75B

MRK Merck & Co Forecast, Technical & Fundamental Analysis

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections... Show more

MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MRK with price predictions
Mar 28, 2025

MRK's Stochastic Oscillator remains in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for MRK crossed bullishly above the 50-day moving average on March 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRK advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

MRK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 246 cases where MRK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MRK as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MRK turned negative on March 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

MRK moved below its 50-day moving average on March 24, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.826) is normal, around the industry mean (5.632). MRK's P/E Ratio (935.643) is considerably higher than the industry average of (48.974). Projected Growth (PEG Ratio) (0.105) is also within normal values, averaging (3.004). Dividend Yield (0.023) settles around the average of (0.161) among similar stocks. P/S Ratio (5.549) is also within normal values, averaging (3.643).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MRK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MRK is expected to report earnings to rise 23.84% to $2.13 per share on April 24

Merck & Co MRK Stock Earnings Reports
Q1'25
Est.
$2.13
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.12
Q1'24
Beat
by $0.14
The last earnings report on February 04 showed earnings per share of $1.72, missing the estimate of $1.81. With 12.39M shares outstanding, the current market capitalization sits at 331.75B.
A.I.Advisor
published Dividends

MRK is expected to pay dividends on April 07, 2025

Merck & Co MRK Stock Dividends
A dividend of $0.81 per share will be paid with a record date of April 07, 2025, and an ex-dividend date of March 17, 2025. The last dividend of $0.81 was paid on January 08. Read more...
A.I. Advisor
published General Information

General Information

a developer of human and animal health products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
126 East Lincoln Avenue
Phone
+1 908 740-4000
Employees
72000
Web
https://www.merck.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRCE2.320.05
+2.20%
Grace Therapeutics Inc
NEM48.08-0.31
-0.64%
Newmont Corp
KRG22.27-0.32
-1.42%
Kite Realty Group Trust
ATUS2.77-0.04
-1.42%
Altice USA
NRIM73.25-1.72
-2.29%
Northrim BanCorp

MRK and Stocks

Correlation & Price change

A.I.dvisor tells us that MRK and AZN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRK and AZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+1.86%
AZN - MRK
27%
Poorly correlated
+1.30%
JNJ - MRK
24%
Poorly correlated
+0.36%
NVS - MRK
23%
Poorly correlated
+1.05%
PFE - MRK
23%
Poorly correlated
+0.80%
GSK - MRK
22%
Poorly correlated
+0.57%
More